TP53 and type 1 diabetes mellitus: Nonetheless, this finding does not exclude the possibility of an altered basal p53 activation in our cohort of type 1 diabetes patients [31] and suggests that different effects of p53 activation among patients and controls are not due to different p53 expression levels.